Psychedelics for Brain Injury: A Mini-Review
TLDR
The current state of the science's relevance to neurorehabilitation is summarized, and may act as a resource for those seeking to understand the precedence for these ongoing clinical trials into psychedelic therapeutics for treatment of brain injury.Abstract:
Objective: Brain injury due to stroke and traumatic brain injury (TBI) is one of the leading causes of disability. Even after engaging in an appropriate rehabilitation program, nearly half of patients with severe traumatic brain injury requiring hospitalization will be left with chronic severe disability. Despite decades of investigation, pharmacologic treatment of brain injury is still a field in its infancy, suffering from a lack of consistently proven drug regimens. Recent clinical trials have begun into the use of psychedelic therapeutics for treatment of brain injury. This brief review aims to summarize the current state of the science’s relevance to neurorehabilitation. Methods: Scoping review of all studies published related to psychedelic therapeutics and brain injury. Results: Recent in vitro, in vivo, and case report studies suggest psychedelic pharmacotherapies may radically alter the future of brain injury treatment through modulation of neuroinflammation, neuroplasticity, hippocampal neurogenesis, and brain complexity. Conclusions: Historical data on the safety of these substances could serve in effect as phase 0 and phase I studies. N,N-Dimethyltryptamine is currently undergoing clinical trials for treatment of stroke. Further phase II trials will illuminate how these promising drugs may treat brain injury, particularly TBI and reperfusion injury from stroke.read more
Citations
More filters
Journal ArticleDOI
If the doors of perception were cleansed, would chronic pain be relieved? Evaluating the benefits and risks of psychedelics.
Robert H. Dworkin,Brian T. Anderson,Nick Andrews,Robert Edwards,Charles S. Grob,Stephen E. Ross,Theodore D. Satterthwaite,Eric C. Strain +7 more
TL;DR: There is considerable promise for the use of psychedelic therapy for pain, but evidence-based recommendations for the design of future studies are needed to ensure that the results of this research are truly informative as discussed by the authors .
Journal ArticleDOI
Nano-Neurogenesis for CNS Diseases and Disorders
Sneham Tiwari,Ajeet Kaushik +1 more
TL;DR: An insight is offered into how neurogenesis could be aided by nanotechnology and what plausible nanomaterials are available to culminate Neurogenesis-related neurological disorders.
Journal ArticleDOI
Psychedelics and fNIRS neuroimaging: exploring new opportunities
TL;DR: The potential of using optical neuroimaging with functional near-infrared spectroscopy (fNIRS) to further explore the changes in brain activity induced by psychedelics is discussed in this paper .
Journal ArticleDOI
The next bet for cerebral aneurysms treatment: Psychedelics
Mustafa Bahagat Younis Ismail,Zaid Aljuboori,Ahmed Muthana,Mayur Sharma,Samer S. Hoz,Norberto Andaluz +5 more
TL;DR: This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
References
More filters
Journal ArticleDOI
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Vanja Dakic,Juliana M. Nascimento,Rafaela C. Sartore,Renata de Moraes Maciel,Dráulio Barros de Araújo,Sidarta Ribeiro,Daniel Martins-de-Souza,Stevens K. Rehen +7 more
TL;DR: In silico analysis reinforced previously reported anti-inflammatory actions of 5-MeO-DMT and revealed modulatory effects on proteins associated with long-term potentiation, the formation of dendritic spines, including those involved in cellular protrusion formation, microtubule dynamics, and cytoskeletal reorganization.
Journal ArticleDOI
Pivotal mental states
TL;DR: It is argued that pivotal mental states serve an important evolutionary function, that is, to aid psychological transformation when actual or perceived environmental pressures demand this, and that serotonergic psychedelics hijack a system that has evolved to mediate rapid and deep learning when its need is sensed.
Journal ArticleDOI
Self-blinding citizen science to explore psychedelic microdosing
Balázs Szigeti,Laura Kartner,Allan Blemings,Fernando Rosas,Amanda Feilding,David J. Nutt,Robin L. Carhart-Harris,David Erritzoe +7 more
TL;DR: In this article, the authors used a self-blinding citizen science initiative, where participants were given online instructions on how to incorporate placebo control into their microdosing routine without clinical supervision.
Journal ArticleDOI
Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke
Roman Urfer,Hans J. Moebius,David Školoudík,Estevo Santamarina,Wakao Sato,Shiro Mita,Keith W. Muir +6 more
TL;DR: Although no significant effects on functional end points were seen in the population as a whole, greater improvement in National Institutes of Health Stroke Scale scores among patients with greater pretreatment deficits seen in post hoc analysis warrants further investigation.
Journal ArticleDOI
Is hippocampal atrophy a future drug target
Vikas Dhikav,Kuljeet Singh Anand +1 more
TL;DR: To what extent does the hippocampal atrophy play a role in the genesis of symptoms of diseases or their progression?